A lawyer who says she gave a drug company the idea to use thalidomide as a cancer treatment has won the right to pursue a claim that the company reneged on the promise of a reward and owes her $300 million.
U.S. District Judge Faith Hochberg in Newark ruled on Wednesday that Beth Jacobson, who allegedly gave Celgene Corp. the thalidomide idea in 1997, can engage in discovery to defeat its motion for dismissal of the suit as time-barred.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
